Dominick P. Purpura Department of Neuroscience

Committee

Pablo Castillo 

Donald Faber   Chair Emeritus, Department of Neuroscience 

Anna Francesconi 

Bryen Jordan 

Kamran Khodakhah   Chair, Department of Neuroscience 

Adam Kohn 

Mark Mehler   Chair, Department of Neurology 

Jose Luis Pena   Education Committee Chair 

 

Committee Responsibilities

  • Reviewing the policies, guidelines and courses for the Graduate Program in Neuroscience 
  • Liaison with the Einstein Graduate Division  
  • Reviewing actions of the Student Advisory Committee 
  • Ensure that all Departmental and Graduate School requirements are met prior to graduation 

Recent News & Events

Grant Award | Dr. Noboru Hiroi
Noboru Hiroi, Ph.D., has been awarded a five-year, $1.8 million grant from the National Institute on Deafness and Other Communication Disorders to investigate the interplay among genes, early social communication and neonatal maternal care in determining the severity of autism spectrum disorder (ASD). Working with a genetic mouse model of ASD, Dr. Hiroi’s lab has observed that newborn mice display an unusual vocalization or “call,” to communicate with their mothers and that this abnormal call reduces the level of maternal care that newborns receive. The researchers will study whether abnormal newborn-to-mother vocalization is caused by ASD-related gene variants and whether this early experience of social communication gone awry worsens ASD-like behaviors through the epigenetic modification of these gene variants. Dr. Hiroi is professor in the Dominick P. Purpura Department of Neuroscience and of psychiatry and behavioral sciences. (1R01DC015776-01A1)...more

Publication | Dr. Steve Walkley
Steven Walkley, D.V.M., Ph.D., has co-authored a study in the August 10 issue of The Lancet showing that the drug 2-hydroxypropyl-β-cyclodextrin (HPβCD) can safely slow NPC1's progression. Patients received monthly or bi-weekly spinal injections of the drug for 18 months. Following the treatment period, biochemical and neurological tests showed that, compared with historical data for patients the same age, patients treated with the drug experienced significantly less cognitive dysfunction, with minimal side effects. Dr. Walkley is director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, in the department of pathology, and in the Saul R. Korey Department of Neurology at Einstein....more

more news and events

 

Contact Us

Rose F. Kennedy Center

1410 Pelham Parkway South

9th Floor

Bronx, NY 10461

Phone: 718-430-2408

Fax: 718-430-8821

 
 
Click here to log in